TITLE

ZYGEM TO DISTRIBUTE PICOPLEX AMPLIFICATION KITS

PUB. DATE
March 2010
SOURCE
Worldwide Biotech;Mar2010, Vol. 22 Issue 3, p5
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports on the agreement of Rubicon Genomics Inc. with ZyGEM to market its PicoPlexâ„¢ single-cell amplification kits in Australia and New Zealand. According to company president James Koziarz, the agreement is another step in the adoption of the company's amplification kits in the global marketplace. He adds that the technology has the capability of performing rapid amplification of nucleic acids from a variety of sample types.
ACCESSION #
48366831

 

Related Articles

  • Rubicon enters into marketing agreement pact with ZyGEM.  // Medical Device Daily;2/4/2010, Vol. 14 Issue 23, p1 

    The article reports on an agreement reached by Rubicon Genomics with ZyGEM to non-exclusively market Rubicon's PicoPlex single-cell amplification kits in Australia and New Zealand. PicoFlex is capable of obtaining the same amount of genomic data for analysis from a single human cell or from...

  • Amplification Kit.  // Drug Discovery & Development;Sep2009, Vol. 12 Issue 8, p37 

    The article evaluates the PicoPlex Single Cell Whole Genome Amplification (WGA) kit from Rubicon Genomics Inc.

  • Lockheed Martin [LMT]: Lockheed Martin, ZyGEM Introduce DNA Analysis System.  // TR2: Terror Response Technology Report;9/29/2010, Vol. 6 Issue 20, p7 

    The article focuses on a new deoxyribonucleic acid (DNA) analysis system called RapI.D. introduced by Lockheed Martin and ZyGEM Corp. Ltd. in 2010.

  • Rubicon Genomics finds its niche in analysis kits. Henderson, Tom // Crain's Detroit Business;11/2/2015, Vol. 31 Issue 44, p0012 

    The article focuses on the revival of Rubicon Genomics after shifting to the development of new products. When James Koziarz entered the company as CEO, it was under economic struggle and in need of a reinvention as it operates by doing contract research for other companies. In 2009, the company...

  • The PCR assay in the preclinical safety evaluation of nucleic acid medicines. Haworth, R.; Pilling, A.M. // Human & Experimental Toxicology;May2000, Vol. 19 Issue 5, p267 

    The polymerase chain reaction (PCR) is a highly efficient gene amplification procedure which is increasingly being applied to the safety assessment of nucleic acid (NA) medicines such as gene therapies and DNA vaccines. Although clinical experience is limited, a number of potential safety issues...

  • Genetic variability in physic nuts cultivated in Northeastern Brazil. Dias Oliveira, Vanice; Carregosa Rabbani, Allivia Rouse; Cruz da Silva, Ana Veruska; da Silva Lédo, Ana // Ciência Rural;jun2013, Vol. 43 Issue 6, p978 

    This research had as objective to characterize genetically individuals of physic nut cultivated in experimental areas in Sergipe, Brazil by means of RAPD molecular markers. Leaves of 40 individuals were collected and DNA was isolated using CTAB 2% method. Were used 30 primers RAPD for DNA...

  • Establishment of a National Taiwan Standard and Working Reagent for Human Parvovirus B19 DNA Nucleic Acid Amplification Techniques (NAT). Yi-Chen Yang; Chia-Jung Chang; Chiung-I Tseng; Der-Yen Wang; Hwei-Fang Cheng; Chia-Po Lin // Journal of Food & Drug Analysis;Oct2008, Vol. 16 Issue 5, p9 

    Mandatory requirements for plasma pools containing a maximum concentration of human parvovirus 1319 DNA will be established in Taiwan in the near future. To facilitate the implementation of the policy, a National Standard and working reagent were established for human parvovirus B19 DNA nucleic...

  • Isothermal Amplification Methods for the Detection of Nucleic Acids in Microfluidic Devices. Zanoli, Laura Maria; Spoto, Giuseppe // Biosensors (2079-6374);Mar2013, Vol. 3 Issue 1, p18 

    Diagnostic tools for biomolecular detection need to fulfill specific requirements in terms of sensitivity, selectivity and high-throughput in order to widen their applicability and to minimize the cost of the assay. The nucleic acid amplification is a key step in DNA detection assays. It...

  • Nucleic acid amplification testing may be effective in diagnosing TB. Blazek, Nicole; Kalvaitis, Katie; Volansky, Rob // Infectious Diseases in Children;Aug2009, Vol. 22 Issue 8, p39 

    The article discusses research which found the effectiveness of nucleic acid amplification testing in diagnosing tuberculosis, referencing a study by F. Laraque published in a 2009 issue of "Clinical Infectious Disease."

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics